203 related articles for article (PubMed ID: 16051739)
41. Breast cancer following treatment for Hodgkin's disease: the need for screening in a young population. Australasian Radiation Oncology Lymphoma Group (AROLG).
O'Brien PC; Barton MB; Fisher R
Australas Radiol; 1995 Aug; 39(3):271-6. PubMed ID: 7487764
[TBL] [Abstract][Full Text] [Related]
42. Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors.
Roberti S; van Leeuwen FE; Ronckers CM; Krul IM; de Vathaire F; Veres C; Diallo I; Janus CPM; Aleman BMP; Russell NS; Hauptmann M
J Natl Cancer Inst; 2022 Sep; 114(9):1270-1278. PubMed ID: 35771630
[TBL] [Abstract][Full Text] [Related]
43. Radiation dose and breast cancer risk in patients treated for cancer of the cervix.
Boice JD; Blettner M; Kleinerman RA; Engholm G; Stovall M; Lisco H; Austin DF; Bosch A; Harlan L; Krementz ET; Latouret HB; Merril JA; Petters LJ; Schulz MD; Wactawski J; Storm HH; Björkholm E; Pettersson F; Bell CM; Coleman MP; Fraser P; Neal FE; Prior P; Choi NW; Hislop TG; Koch M; Kreiger N; Robb D; Robson D; Thomson DH; Lochmüller H; von Fournier D; Frischkorn R; Kjørstad KE; Rimpela A; Pejovic MH; Kirn VP; Stankusova H; Pisani P; Sigurdsson K; Hutchison GB; MacMahon B
Int J Cancer; 1989 Jul; 44(1):7-16. PubMed ID: 2744900
[TBL] [Abstract][Full Text] [Related]
44. Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
Torok JA; Wu Y; Prosnitz LR; Kim GJ; Beaven AW; Diehl LF; Kelsey CR
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):54-9. PubMed ID: 25863754
[TBL] [Abstract][Full Text] [Related]
45. The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma.
Maraldo MV; Jørgensen M; Brodin NP; Aznar MC; Vogelius IR; Petersen PM; Berthelsen AK; Christensen CB; Hjalgrim LL; Specht L
Pediatr Blood Cancer; 2014 Apr; 61(4):717-22. PubMed ID: 24660228
[TBL] [Abstract][Full Text] [Related]
46. Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
Almagro-Casado E; Sánchez A; Cantos B; Salas C; Pérez-Callejo D; Provencio M
Clin Transl Oncol; 2016 Jan; 18(1):99-106. PubMed ID: 26530956
[TBL] [Abstract][Full Text] [Related]
47. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
Filippi AR; Ragona R; Piva C; Scafa D; Fiandra C; Fusella M; Giglioli FR; Lohr F; Ricardi U
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):161-8. PubMed ID: 25863763
[TBL] [Abstract][Full Text] [Related]
48. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer.
Terenziani M; Massimino M; Magazzù D; Gandola L; Capri G; Carcangiu ML; Catania S; Di Russo A; Gennaro M; Meazza C; Podda M; Schiavello E; Valagussa P
Eur J Cancer; 2015 Sep; 51(13):1667-74. PubMed ID: 26092639
[TBL] [Abstract][Full Text] [Related]
49. Secondary breast cancer in Hodgkin's lymphoma survivors.
Crump M; Hodgson D
J Clin Oncol; 2009 Sep; 27(26):4229-31. PubMed ID: 19667263
[No Abstract] [Full Text] [Related]
50. Breast cancer following treatment for Hodgkin's disease.
Langlands AO
Australas Radiol; 1995 Aug; 39(3):207. PubMed ID: 7487750
[No Abstract] [Full Text] [Related]
51. Dosimetry of the breast for determining carcinogenic risk in mantle irradiation.
Zellmer DL; Wilson JF; Janjan NA
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1343-51. PubMed ID: 1938534
[TBL] [Abstract][Full Text] [Related]
52. The risk of multiple primary breast and thyroid carcinomas.
Adjadj E; Rubino C; Shamsaldim A; Lê MG; Schlumberger M; de Vathaire F
Cancer; 2003 Sep; 98(6):1309-17. PubMed ID: 12973856
[TBL] [Abstract][Full Text] [Related]
53. The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.
Howell SJ; Searle C; Goode V; Gardener T; Linton K; Cowan RA; Harris MA; Hopwood P; Swindell R; Norman A; Kennedy J; Howell A; Wardley AM; Radford JA
Br J Cancer; 2009 Aug; 101(4):582-8. PubMed ID: 19672261
[TBL] [Abstract][Full Text] [Related]
54. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma.
Huang J; Walker R; Groome PG; Shelley W; Mackillop WJ
Cancer; 2001 Sep; 92(6):1411-8. PubMed ID: 11745217
[TBL] [Abstract][Full Text] [Related]
55. Breast cancer in women following mantle irradiation for Hodgkin's disease.
Peters MH; Sonpal IM; Batra MK
Am Surg; 1995 Sep; 61(9):763-6. PubMed ID: 7661471
[TBL] [Abstract][Full Text] [Related]
56. Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.
Thomas J; Fermé C; Noordijk EM; Morschhauser F; Girinsky T; Gaillard I; Lugtenburg PJ; André M; Lybeert MLM; Stamatoullas A; Beijert M; Hélias P; Eghbali H; Gabarre J; van der Maazen RWM; Jaubert J; Bouabdallah K; Boulat O; Roesink JM; Christian B; Ong F; Bordessoule D; Tertian G; Gonzalez H; Vranovsky A; Quittet P; Tirelli U; de Jong D; Audouin J; Aleman BMP; Henry-Amar M
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1133-1145. PubMed ID: 29229324
[TBL] [Abstract][Full Text] [Related]
57. A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study.
Brooks JD; Boice JD; Shore RE; Reiner AS; Smith SA; Bernstein L; Knight JA; Lynch CF; John EM; Malone KE; Mellemkjaer L; Langballe R; Liang X; Woods M; Tischkowitz M; Concannon P; Stram DO;
Breast; 2020 Dec; 54():62-69. PubMed ID: 32927238
[TBL] [Abstract][Full Text] [Related]
58. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma.
Zablotska LB; Neugut AI
Cancer; 2003 Mar; 97(6):1404-11. PubMed ID: 12627503
[TBL] [Abstract][Full Text] [Related]
59. Pancreatic cancer risk after treatment of Hodgkin lymphoma.
Dores GM; Curtis RE; van Leeuwen FE; Stovall M; Hall P; Lynch CF; Smith SA; Weathers RE; Storm HH; Hodgson DC; Kleinerman RA; Joensuu H; Johannesen TB; Andersson M; Holowaty EJ; Kaijser M; Pukkala E; Vaalavirta L; Fossa SD; Langmark F; Travis LB; Fraumeni JF; Aleman BM; Morton LM; Gilbert ES
Ann Oncol; 2014 Oct; 25(10):2073-2079. PubMed ID: 25185241
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
Chang ET; Lau EC; Mowat FS; Teta MJ
Cancer Causes Control; 2017 Sep; 28(9):971-979. PubMed ID: 28755241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
